Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860404 · ClinicalTrials.gov registry record · Phase 2
BCAA Supplementation for Concussion
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT01860404 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 42 participants.
The verdict
NCT01860404, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAA's) in the treatment of concussion. The aim of the study is to determine whether, compared to placebo treatment, administration of BCAA's, at one or more doses, after a concussion improves neurocognitive recovery at one or more time-periods post concussion.
Interventions
- DRUG Placebo solution
- DRUG Branched Chain Amino Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-01 |
| Est. Completion | 2023-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860404
The ClinicalTrials.gov registry entry for NCT01860404 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo solution is the first listed.
NCT01860404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860404 about?
NCT01860404 is a clinical study titled "BCAA Supplementation for Concussion". This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAA's) in the treatment of concussion. The aim of the study is to determine whether, compared to placebo treatment, administration of BCAA's, at one or more doses, a...
What is the current status of trial NCT01860404?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2014-01. Estimated completion is 2023-01.
What interventions are being tested in trial NCT01860404?
The interventions under investigation include: Placebo solution (DRUG), Branched Chain Amino Acids (DRUG).
Who is sponsoring clinical trial NCT01860404?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.